We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chemical Used in COVID-19 Therapy Development Subject of Allele Patent Lawsuits
Chemical Used in COVID-19 Therapy Development Subject of Allele Patent Lawsuits
San Diego-based Allele Biotechnology has filed lawsuits against Regeneron Pharmaceuticals, Pfizer and BioNTech, alleging infringement of its patent for mNeonGreen, a reagent used to develop COVID-19 therapies.